Mikael Frederiksen

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green, Ken H. Young, Carlo Visco et al. · Journal of Clinical Oncology · 2012 · 683 citations · Full text

Medicine, Hematology, Oncology +14

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

Thomas Stauffer Larsen, Katrine Fladeland Iversen, Esben Hansen et al. · Leukemia Research · 2013 · 91 citations

Life Sciences, Hematology, Immunology +6

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

Trine Alma Knudsen, Vibe Skov, Kristen E. Stevenson et al. · Blood Advances · 2021 · 64 citations · Full text

Medicine, Hematology, Oncology +16

Real‐world outcomes for 205 patients with chronic lymphocytic leukemia treated with ibrutinib

Kathrine Aarup, Emelie Curovic Rotbain, Lisbeth Enggaard et al. · European Journal Of Haematology · 2020 · 56 citations · Full text

Medicine, Hematology, Oncology +12

Strategies to improve patient-reported outcome completion rates in longitudinal studies

Lene Kongsgaard Nielsen, Madeleine King, Sören Möller et al. · Quality of Life Research · 2019 · 43 citations · Full text

Pharmacy, Health Informatics, Clinical Epidemiology +16